-
1
-
-
0028272883
-
Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
-
H. Vlassara, R. Bucala, and L. Striker Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab. Invest 70 1994 138 151 (Pubitemid 24090096)
-
(1994)
Laboratory Investigation
, vol.70
, Issue.2
, pp. 138-151
-
-
Vlassara, H.1
Bucala, R.2
Striker, L.3
-
2
-
-
73249122895
-
RAGE, glomerulosclerosis and proteinuria: Roles in podocytes and endothelial cells
-
V. D'Agati, S.F. Yan, and R. Ramasamy RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells Trends Endocrinol. Metab. 21 2010 50 56
-
(2010)
Trends Endocrinol. Metab.
, vol.21
, pp. 50-56
-
-
D'Agati, V.1
Yan, S.F.2
Ramasamy, R.3
-
3
-
-
21044443182
-
Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
-
DOI 10.2174/1381612054367300
-
S. Yamagishi, and T. Imaizumi Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr. Pharm. Des. 11 2005 2279 2299 (Pubitemid 40872698)
-
(2005)
Current Pharmaceutical Design
, vol.11
, Issue.18
, pp. 2279-2299
-
-
Yamagishi, S.-I.1
Imaizumi, T.2
-
4
-
-
38449119409
-
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
-
J. Shepherd, J.J. Kastelein, and V. Bittner Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study Clin. J. Am. Soc. Nephrol. 2 2007 1131 1139
-
(2007)
Clin. J. Am. Soc. Nephrol.
, vol.2
, pp. 1131-1139
-
-
Shepherd, J.1
Kastelein, J.J.2
Bittner, V.3
-
5
-
-
49749144405
-
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease
-
L.F. Fried Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease Kidney Int. 74 2008 571 576
-
(2008)
Kidney Int.
, vol.74
, pp. 571-576
-
-
Fried, L.F.1
-
6
-
-
17444384875
-
The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis
-
R.C. Ozsoy, M.G. Koopman, and J.J. Kastelein The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis Clin. Nephrol. 63 2005 245 249 (Pubitemid 40542383)
-
(2005)
Clinical Nephrology
, vol.63
, Issue.4
, pp. 245-249
-
-
Ozsoy, R.C.1
Koopman, M.G.2
Kastelein, J.J.P.3
Arisz, L.4
-
7
-
-
0041468953
-
Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance
-
H. Sinzinger, H. Kritz, and C.D. Furberg Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance Med. Sci. Monit. 9 2003 PI88 PI92
-
(2003)
Med. Sci. Monit.
, vol.9
-
-
Sinzinger, H.1
Kritz, H.2
Furberg, C.D.3
-
8
-
-
0034069293
-
Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy
-
M. Buemi, A. Allegra, and F. Corica Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy Clin. Pharmacol. Ther. 67 2000 427 431 (Pubitemid 30246821)
-
(2000)
Clinical Pharmacology and Therapeutics
, vol.67
, Issue.4
, pp. 427-431
-
-
Buemi, M.1
Allegra, A.2
Corica, F.3
Aloisi, C.4
Giacobbe, M.5
Pettinato, G.6
Corsonello, A.7
Senatore, M.8
Frisina, N.9
-
9
-
-
77953794875
-
Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1
-
H.H. Chen, T.W. Chen, and H. Lin Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1 Mol. Pharmacol. 78 2010 36 45
-
(2010)
Mol. Pharmacol.
, vol.78
, pp. 36-45
-
-
Chen, H.H.1
Chen, T.W.2
Lin, H.3
-
10
-
-
49249134599
-
Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression
-
T. Fujii, M. Onimaru, and Y. Yonemitsu Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2785 H2791
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.294
-
-
Fujii, T.1
Onimaru, M.2
Yonemitsu, Y.3
-
11
-
-
33746019939
-
Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression
-
DOI 10.1074/jbc.M602110200
-
S. Yamagishi, K. Nalkamura, and T. Matsui Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression J. Biol. Chem. 281 2006 20213 20220 (Pubitemid 44065796)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.29
, pp. 20213-20220
-
-
Yamagishi, S.-I.1
Nakamura, K.2
Matsui, T.3
Inagaki, Y.4
Takenaka, K.5
Jinnouchi, Y.6
Yoshida, Y.7
Matsuura, T.8
Narama, I.9
Motomiya, Y.10
Takeuchi, M.11
Inoue, H.12
Yoshimura, A.13
Bucala, R.14
Imaizumi, T.15
-
12
-
-
79751527695
-
Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis
-
S. Maeda, T. Matsui, and M. Takeuchi Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis Pharmacol. Res. 63 2010 241 248
-
(2010)
Pharmacol. Res.
, vol.63
, pp. 241-248
-
-
Maeda, S.1
Matsui, T.2
Takeuchi, M.3
-
13
-
-
77955414324
-
Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation
-
Y. Ide, T. Matsui, and Y. Ishibashi Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation Microvasc. Res. 80 2010 227 232
-
(2010)
Microvasc. Res.
, vol.80
, pp. 227-232
-
-
Ide, Y.1
Matsui, T.2
Ishibashi, Y.3
-
14
-
-
33751171940
-
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes
-
C. Cuccurullo, A. Iezzi, and M.L. Fazia Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes Arterioscler. Thromb. Vasc. Biol. 26 2006 2716 2723
-
(2006)
Arterioscler. Thromb. Vasc. Biol.
, vol.26
, pp. 2716-2723
-
-
Cuccurullo, C.1
Iezzi, A.2
Fazia, M.L.3
-
15
-
-
77649291952
-
Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells
-
E. Alvarez, B.K. Rodiño-Janeiro, and R. Ucieda-Somoza Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells J. Cardiovasc. Pharmacol. 55 2010 203 212
-
(2010)
J. Cardiovasc. Pharmacol.
, vol.55
, pp. 203-212
-
-
Alvarez, E.1
Rodiño-Janeiro, B.K.2
Ucieda-Somoza, R.3
-
16
-
-
0343048978
-
Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
-
A.H. Wagner, T. Köhler, and U. Rückschloss Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler. Thromb. Vasc. Biol. 20 2000 61 69 (Pubitemid 30048347)
-
(2000)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.20
, Issue.1
, pp. 61-69
-
-
Wagner, A.H.1
Kohler, T.2
Ruckschloss, U.3
Just, I.4
Hecker, M.5
-
17
-
-
77955434278
-
New pathways to renal damage: Role of ADMA in retarding renal disease progression
-
S. Ueda, S. Yamagishi, and S. Okuda New pathways to renal damage: role of ADMA in retarding renal disease progression J. Nephrol. 23 2010 377 386
-
(2010)
J. Nephrol.
, vol.23
, pp. 377-386
-
-
Ueda, S.1
Yamagishi, S.2
Okuda, S.3
-
18
-
-
65249184373
-
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes
-
E. Schepers, G. Glorieux, and A. Dhondt Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes Nephrol. Dial. Transplant. 24 2009 1429 1435
-
(2009)
Nephrol. Dial. Transplant.
, vol.24
, pp. 1429-1435
-
-
Schepers, E.1
Glorieux, G.2
Dhondt, A.3
-
19
-
-
0037143637
-
Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
-
DOI 10.1161/01.CIR.0000027109.14149.67
-
K.Y. Lin, A. Ito, and T. Asagami Impaired nitric oxide synthase pathway in diabetes mellitus role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 2002 987 992 (Pubitemid 34925335)
-
(2002)
Circulation
, vol.106
, Issue.8
, pp. 987-992
-
-
Lin, K.Y.1
Ito, A.2
Asagami, T.3
Tsao, P.S.4
Adimoolam, S.5
Kimoto, M.6
Tsuji, H.7
Reaven, G.M.8
Cooke, J.P.9
-
20
-
-
19544377337
-
Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein
-
DOI 10.1097/01.fjc.0000159642.44523.7f
-
Q.F. Yin, and Y. Xiong Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein J. Cardiovasc. Pharmacol. 45 2005 525 532 (Pubitemid 40734572)
-
(2005)
Journal of Cardiovascular Pharmacology
, vol.45
, Issue.6
, pp. 525-532
-
-
Yin, Q.-F.1
Xiong, Y.2
|